nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Methylprednisolone—multiple sclerosis	0.0919	0.124	CbGbCtD
Lomitapide—CYP3A4—Fingolimod—multiple sclerosis	0.0855	0.115	CbGbCtD
Lomitapide—ABCB1—Mitoxantrone—multiple sclerosis	0.067	0.0901	CbGbCtD
Lomitapide—ABCB1—Betamethasone—multiple sclerosis	0.0598	0.0803	CbGbCtD
Lomitapide—ABCB1—Prednisolone—multiple sclerosis	0.059	0.0793	CbGbCtD
Lomitapide—ABCB1—Prednisone—multiple sclerosis	0.0557	0.0749	CbGbCtD
Lomitapide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0551	0.074	CbGbCtD
Lomitapide—CYP3A4—Triamcinolone—multiple sclerosis	0.0417	0.0561	CbGbCtD
Lomitapide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0402	0.054	CbGbCtD
Lomitapide—CYP3A4—Betamethasone—multiple sclerosis	0.0358	0.0481	CbGbCtD
Lomitapide—CYP3A4—Prednisolone—multiple sclerosis	0.0353	0.0475	CbGbCtD
Lomitapide—ABCB1—Dexamethasone—multiple sclerosis	0.0348	0.0467	CbGbCtD
Lomitapide—CYP3A4—Prednisone—multiple sclerosis	0.0334	0.0449	CbGbCtD
Lomitapide—ABCB1—Methotrexate—multiple sclerosis	0.0279	0.0376	CbGbCtD
Lomitapide—CYP3A4—Dexamethasone—multiple sclerosis	0.0208	0.028	CbGbCtD
Lomitapide—MTTP—Chylomicron-mediated lipid transport—APOE—multiple sclerosis	0.00185	0.114	CbGpPWpGaD
Lomitapide—MTTP—Statin Pathway—APOE—multiple sclerosis	0.00121	0.0743	CbGpPWpGaD
Lomitapide—MTTP—Lipoprotein metabolism—APOE—multiple sclerosis	0.00118	0.0723	CbGpPWpGaD
Lomitapide—MTTP—Lipoprotein metabolism—ALB—multiple sclerosis	0.000922	0.0566	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	0.000782	0.048	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—ALB—multiple sclerosis	0.000613	0.0376	CbGpPWpGaD
Lomitapide—Myalgia—Azathioprine—multiple sclerosis	0.000558	0.00233	CcSEcCtD
Lomitapide—Arthralgia—Azathioprine—multiple sclerosis	0.000558	0.00233	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000554	0.00231	CcSEcCtD
Lomitapide—Dry skin—Dexamethasone—multiple sclerosis	0.000552	0.0023	CcSEcCtD
Lomitapide—Dry skin—Betamethasone—multiple sclerosis	0.000552	0.0023	CcSEcCtD
Lomitapide—Discomfort—Azathioprine—multiple sclerosis	0.000551	0.0023	CcSEcCtD
Lomitapide—Chills—Mitoxantrone—multiple sclerosis	0.000546	0.00228	CcSEcCtD
Lomitapide—Ecchymosis—Methotrexate—multiple sclerosis	0.000546	0.00228	CcSEcCtD
Lomitapide—Feeling abnormal—Cladribine—multiple sclerosis	0.000542	0.00226	CcSEcCtD
Lomitapide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000538	0.00224	CcSEcCtD
Lomitapide—Infection—Azathioprine—multiple sclerosis	0.000531	0.00221	CcSEcCtD
Lomitapide—Body temperature increased—Cladribine—multiple sclerosis	0.00052	0.00217	CcSEcCtD
Lomitapide—Abdominal pain—Cladribine—multiple sclerosis	0.00052	0.00217	CcSEcCtD
Lomitapide—Skin disorder—Azathioprine—multiple sclerosis	0.000519	0.00217	CcSEcCtD
Lomitapide—Back pain—Mitoxantrone—multiple sclerosis	0.000512	0.00214	CcSEcCtD
Lomitapide—Infestation NOS—Methylprednisolone—multiple sclerosis	0.00051	0.00213	CcSEcCtD
Lomitapide—Infestation—Methylprednisolone—multiple sclerosis	0.00051	0.00213	CcSEcCtD
Lomitapide—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000491	0.00205	CcSEcCtD
Lomitapide—Anaemia—Mitoxantrone—multiple sclerosis	0.00049	0.00204	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000487	0.00203	CcSEcCtD
Lomitapide—Dry skin—Prednisone—multiple sclerosis	0.000481	0.002	CcSEcCtD
Lomitapide—Malaise—Mitoxantrone—multiple sclerosis	0.000478	0.00199	CcSEcCtD
Lomitapide—Asthenia—Cladribine—multiple sclerosis	0.000472	0.00197	CcSEcCtD
Lomitapide—Weight decreased—Betamethasone—multiple sclerosis	0.000471	0.00196	CcSEcCtD
Lomitapide—Weight decreased—Dexamethasone—multiple sclerosis	0.000471	0.00196	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000462	0.00193	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000462	0.00192	CcSEcCtD
Lomitapide—Abdominal distension—Prednisone—multiple sclerosis	0.000456	0.0019	CcSEcCtD
Lomitapide—Myalgia—Mitoxantrone—multiple sclerosis	0.000451	0.00188	CcSEcCtD
Lomitapide—Arthralgia—Mitoxantrone—multiple sclerosis	0.000451	0.00188	CcSEcCtD
Lomitapide—Chest pain—Mitoxantrone—multiple sclerosis	0.000451	0.00188	CcSEcCtD
Lomitapide—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00045	0.00188	CcSEcCtD
Lomitapide—Diarrhoea—Cladribine—multiple sclerosis	0.00045	0.00188	CcSEcCtD
Lomitapide—Discomfort—Mitoxantrone—multiple sclerosis	0.000446	0.00186	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000445	0.0273	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000445	0.0273	CbGpPWpGaD
Lomitapide—Feeling abnormal—Azathioprine—multiple sclerosis	0.000441	0.00184	CcSEcCtD
Lomitapide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000437	0.00182	CcSEcCtD
Lomitapide—Dizziness—Cladribine—multiple sclerosis	0.000435	0.00181	CcSEcCtD
Lomitapide—Infection—Mitoxantrone—multiple sclerosis	0.000429	0.00179	CcSEcCtD
Lomitapide—Eye disorder—Methylprednisolone—multiple sclerosis	0.000428	0.00178	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000427	0.0262	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000427	0.0262	CbGpPWpGaD
Lomitapide—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000425	0.00177	CcSEcCtD
Lomitapide—Abdominal pain—Azathioprine—multiple sclerosis	0.000423	0.00176	CcSEcCtD
Lomitapide—Body temperature increased—Azathioprine—multiple sclerosis	0.000423	0.00176	CcSEcCtD
Lomitapide—Skin disorder—Mitoxantrone—multiple sclerosis	0.00042	0.00175	CcSEcCtD
Lomitapide—Vomiting—Cladribine—multiple sclerosis	0.000418	0.00174	CcSEcCtD
Lomitapide—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000418	0.00174	CcSEcCtD
Lomitapide—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000413	0.00172	CcSEcCtD
Lomitapide—Headache—Cladribine—multiple sclerosis	0.000412	0.00172	CcSEcCtD
Lomitapide—Weight decreased—Prednisone—multiple sclerosis	0.00041	0.00171	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000405	0.00169	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000403	0.00168	CcSEcCtD
Lomitapide—Malnutrition—Methylprednisolone—multiple sclerosis	0.000399	0.00166	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000394	0.00164	CcSEcCtD
Lomitapide—Malaise—Prednisolone—multiple sclerosis	0.000392	0.00163	CcSEcCtD
Lomitapide—Nausea—Cladribine—multiple sclerosis	0.000391	0.00163	CcSEcCtD
Lomitapide—Vertigo—Prednisolone—multiple sclerosis	0.00039	0.00163	CcSEcCtD
Lomitapide—Eye disorder—Dexamethasone—multiple sclerosis	0.000389	0.00162	CcSEcCtD
Lomitapide—Eye disorder—Betamethasone—multiple sclerosis	0.000389	0.00162	CcSEcCtD
Lomitapide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000388	0.00162	CcSEcCtD
Lomitapide—Back pain—Triamcinolone—multiple sclerosis	0.000387	0.00161	CcSEcCtD
Lomitapide—Somnolence—Mitoxantrone—multiple sclerosis	0.000384	0.0016	CcSEcCtD
Lomitapide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00038	0.00159	CcSEcCtD
Lomitapide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000376	0.00157	CcSEcCtD
Lomitapide—Fatigue—Mitoxantrone—multiple sclerosis	0.000373	0.00155	CcSEcCtD
Lomitapide—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000371	0.00155	CcSEcCtD
Lomitapide—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00037	0.00154	CcSEcCtD
Lomitapide—Constipation—Mitoxantrone—multiple sclerosis	0.00037	0.00154	CcSEcCtD
Lomitapide—Diarrhoea—Azathioprine—multiple sclerosis	0.000366	0.00153	CcSEcCtD
Lomitapide—Discomfort—Prednisolone—multiple sclerosis	0.000365	0.00152	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000363	0.00151	CcSEcCtD
Lomitapide—Malaise—Triamcinolone—multiple sclerosis	0.00036	0.0015	CcSEcCtD
Lomitapide—Malaise—Methylprednisolone—multiple sclerosis	0.00036	0.0015	CcSEcCtD
Lomitapide—Vertigo—Triamcinolone—multiple sclerosis	0.000359	0.0015	CcSEcCtD
Lomitapide—Vertigo—Methylprednisolone—multiple sclerosis	0.000358	0.00149	CcSEcCtD
Lomitapide—Connective tissue disorder—Prednisone—multiple sclerosis	0.000356	0.00149	CcSEcCtD
Lomitapide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000356	0.00149	CcSEcCtD
Lomitapide—Dizziness—Azathioprine—multiple sclerosis	0.000354	0.00147	CcSEcCtD
Lomitapide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000353	0.00147	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000343	0.00143	CcSEcCtD
Lomitapide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000342	0.00142	CcSEcCtD
Lomitapide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000342	0.00142	CcSEcCtD
Lomitapide—Myalgia—Triamcinolone—multiple sclerosis	0.00034	0.00142	CcSEcCtD
Lomitapide—Vomiting—Azathioprine—multiple sclerosis	0.00034	0.00142	CcSEcCtD
Lomitapide—Arthralgia—Methylprednisolone—multiple sclerosis	0.000339	0.00142	CcSEcCtD
Lomitapide—Myalgia—Methylprednisolone—multiple sclerosis	0.000339	0.00142	CcSEcCtD
Lomitapide—Eye disorder—Prednisone—multiple sclerosis	0.000339	0.00141	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—multiple sclerosis	0.000338	0.00141	CcSEcCtD
Lomitapide—Infestation—Methotrexate—multiple sclerosis	0.000338	0.00141	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000337	0.00141	CcSEcCtD
Lomitapide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000336	0.0014	CcSEcCtD
Lomitapide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000336	0.0014	CcSEcCtD
Lomitapide—Discomfort—Triamcinolone—multiple sclerosis	0.000336	0.0014	CcSEcCtD
Lomitapide—Discomfort—Methylprednisolone—multiple sclerosis	0.000335	0.0014	CcSEcCtD
Lomitapide—Headache—Azathioprine—multiple sclerosis	0.000335	0.0014	CcSEcCtD
Lomitapide—Dry mouth—Triamcinolone—multiple sclerosis	0.000333	0.00139	CcSEcCtD
Lomitapide—Malaise—Betamethasone—multiple sclerosis	0.000327	0.00136	CcSEcCtD
Lomitapide—Malaise—Dexamethasone—multiple sclerosis	0.000327	0.00136	CcSEcCtD
Lomitapide—Vertigo—Dexamethasone—multiple sclerosis	0.000326	0.00136	CcSEcCtD
Lomitapide—Vertigo—Betamethasone—multiple sclerosis	0.000326	0.00136	CcSEcCtD
Lomitapide—Infection—Triamcinolone—multiple sclerosis	0.000324	0.00135	CcSEcCtD
Lomitapide—Infection—Methylprednisolone—multiple sclerosis	0.000323	0.00135	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—multiple sclerosis	0.000322	0.00134	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000319	0.00133	CcSEcCtD
Lomitapide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000319	0.00133	CcSEcCtD
Lomitapide—Paraesthesia—Prednisolone—multiple sclerosis	0.000318	0.00133	CcSEcCtD
Lomitapide—Nausea—Azathioprine—multiple sclerosis	0.000318	0.00132	CcSEcCtD
Lomitapide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000316	0.00132	CcSEcCtD
Lomitapide—Malnutrition—Prednisone—multiple sclerosis	0.000316	0.00132	CcSEcCtD
Lomitapide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000315	0.00131	CcSEcCtD
Lomitapide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000315	0.00131	CcSEcCtD
Lomitapide—Asthenia—Mitoxantrone—multiple sclerosis	0.00031	0.00129	CcSEcCtD
Lomitapide—Myalgia—Dexamethasone—multiple sclerosis	0.000309	0.00129	CcSEcCtD
Lomitapide—Myalgia—Betamethasone—multiple sclerosis	0.000309	0.00129	CcSEcCtD
Lomitapide—Discomfort—Betamethasone—multiple sclerosis	0.000305	0.00127	CcSEcCtD
Lomitapide—Discomfort—Dexamethasone—multiple sclerosis	0.000305	0.00127	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000299	0.00125	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—multiple sclerosis	0.000297	0.00124	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000297	0.00124	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000296	0.00124	CcSEcCtD
Lomitapide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000296	0.00123	CcSEcCtD
Lomitapide—Infection—Betamethasone—multiple sclerosis	0.000294	0.00123	CcSEcCtD
Lomitapide—Infection—Dexamethasone—multiple sclerosis	0.000294	0.00123	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000293	0.00122	CcSEcCtD
Lomitapide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000293	0.00122	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000292	0.00122	CcSEcCtD
Lomitapide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000292	0.00122	CcSEcCtD
Lomitapide—Anaemia—Prednisone—multiple sclerosis	0.000292	0.00122	CcSEcCtD
Lomitapide—Nervous system disorder—Betamethasone—multiple sclerosis	0.00029	0.00121	CcSEcCtD
Lomitapide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00029	0.00121	CcSEcCtD
Lomitapide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000287	0.0012	CcSEcCtD
Lomitapide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000286	0.00119	CcSEcCtD
Lomitapide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000286	0.00119	CcSEcCtD
Lomitapide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000286	0.00119	CcSEcCtD
Lomitapide—Malaise—Prednisone—multiple sclerosis	0.000285	0.00119	CcSEcCtD
Lomitapide—Vertigo—Prednisone—multiple sclerosis	0.000284	0.00118	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—multiple sclerosis	0.000283	0.00118	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000281	0.00117	CcSEcCtD
Lomitapide—Fatigue—Triamcinolone—multiple sclerosis	0.000281	0.00117	CcSEcCtD
Lomitapide—Fatigue—Methylprednisolone—multiple sclerosis	0.000281	0.00117	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—FAS—multiple sclerosis	0.00028	0.0172	CbGpPWpGaD
Lomitapide—Vomiting—Mitoxantrone—multiple sclerosis	0.000275	0.00115	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000274	0.0168	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000274	0.0168	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000273	0.00114	CcSEcCtD
Lomitapide—Chills—Methotrexate—multiple sclerosis	0.000272	0.00113	CcSEcCtD
Lomitapide—Headache—Mitoxantrone—multiple sclerosis	0.000271	0.00113	CcSEcCtD
Lomitapide—MTTP—Metabolism—SRM—multiple sclerosis	0.00027	0.0166	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00027	0.00112	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00027	0.00112	CcSEcCtD
Lomitapide—Myalgia—Prednisone—multiple sclerosis	0.000269	0.00112	CcSEcCtD
Lomitapide—Arthralgia—Prednisone—multiple sclerosis	0.000269	0.00112	CcSEcCtD
Lomitapide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000269	0.00112	CcSEcCtD
Lomitapide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000268	0.00112	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000267	0.00111	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000266	0.00111	CcSEcCtD
Lomitapide—Paraesthesia—Betamethasone—multiple sclerosis	0.000266	0.00111	CcSEcCtD
Lomitapide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000266	0.00111	CcSEcCtD
Lomitapide—Discomfort—Prednisone—multiple sclerosis	0.000266	0.00111	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—multiple sclerosis	0.000264	0.0011	CcSEcCtD
Lomitapide—Dyspepsia—Dexamethasone—multiple sclerosis	0.00026	0.00109	CcSEcCtD
Lomitapide—Dyspepsia—Betamethasone—multiple sclerosis	0.00026	0.00109	CcSEcCtD
Lomitapide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000258	0.00107	CcSEcCtD
Lomitapide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000257	0.00107	CcSEcCtD
Lomitapide—Decreased appetite—Betamethasone—multiple sclerosis	0.000257	0.00107	CcSEcCtD
Lomitapide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000257	0.00107	CcSEcCtD
Lomitapide—Nausea—Mitoxantrone—multiple sclerosis	0.000257	0.00107	CcSEcCtD
Lomitapide—Infection—Prednisone—multiple sclerosis	0.000256	0.00107	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000255	0.00107	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000255	0.00107	CcSEcCtD
Lomitapide—Back pain—Methotrexate—multiple sclerosis	0.000255	0.00106	CcSEcCtD
Lomitapide—Fatigue—Dexamethasone—multiple sclerosis	0.000255	0.00106	CcSEcCtD
Lomitapide—Fatigue—Betamethasone—multiple sclerosis	0.000255	0.00106	CcSEcCtD
Lomitapide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000253	0.0156	CbGpPWpGaD
Lomitapide—Nervous system disorder—Prednisone—multiple sclerosis	0.000253	0.00105	CcSEcCtD
Lomitapide—Skin disorder—Prednisone—multiple sclerosis	0.00025	0.00104	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000249	0.00104	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000245	0.00102	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—multiple sclerosis	0.000244	0.00102	CcSEcCtD
Lomitapide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000244	0.00102	CcSEcCtD
Lomitapide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000244	0.00102	CcSEcCtD
Lomitapide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000243	0.0149	CbGpPWpGaD
Lomitapide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000242	0.00101	CcSEcCtD
Lomitapide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000242	0.00101	CcSEcCtD
Lomitapide—Malaise—Methotrexate—multiple sclerosis	0.000238	0.000992	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—multiple sclerosis	0.000237	0.000988	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000235	0.000979	CcSEcCtD
Lomitapide—Dizziness—Prednisolone—multiple sclerosis	0.000235	0.000978	CcSEcCtD
Lomitapide—Asthenia—Triamcinolone—multiple sclerosis	0.000234	0.000975	CcSEcCtD
Lomitapide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000234	0.000975	CcSEcCtD
Lomitapide—Abdominal pain—Betamethasone—multiple sclerosis	0.000234	0.000975	CcSEcCtD
Lomitapide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000234	0.000975	CcSEcCtD
Lomitapide—Body temperature increased—Betamethasone—multiple sclerosis	0.000234	0.000975	CcSEcCtD
Lomitapide—Asthenia—Methylprednisolone—multiple sclerosis	0.000233	0.000973	CcSEcCtD
Lomitapide—Paraesthesia—Prednisone—multiple sclerosis	0.000231	0.000965	CcSEcCtD
Lomitapide—Dyspepsia—Prednisone—multiple sclerosis	0.000227	0.000946	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—multiple sclerosis	0.000225	0.000937	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—multiple sclerosis	0.000225	0.000937	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—multiple sclerosis	0.000225	0.000937	CcSEcCtD
Lomitapide—Decreased appetite—Prednisone—multiple sclerosis	0.000224	0.000934	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000223	0.00093	CcSEcCtD
Lomitapide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000223	0.000928	CcSEcCtD
Lomitapide—Fatigue—Prednisone—multiple sclerosis	0.000222	0.000926	CcSEcCtD
Lomitapide—Headache—Prednisolone—multiple sclerosis	0.000222	0.000926	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—multiple sclerosis	0.000222	0.000925	CcSEcCtD
Lomitapide—Constipation—Prednisone—multiple sclerosis	0.00022	0.000919	CcSEcCtD
Lomitapide—Dizziness—Triamcinolone—multiple sclerosis	0.000216	0.000899	CcSEcCtD
Lomitapide—Dizziness—Methylprednisolone—multiple sclerosis	0.000215	0.000897	CcSEcCtD
Lomitapide—Infection—Methotrexate—multiple sclerosis	0.000214	0.000892	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisone—multiple sclerosis	0.000212	0.000885	CcSEcCtD
Lomitapide—Asthenia—Betamethasone—multiple sclerosis	0.000212	0.000885	CcSEcCtD
Lomitapide—Asthenia—Dexamethasone—multiple sclerosis	0.000212	0.000885	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000211	0.000881	CcSEcCtD
Lomitapide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000211	0.000879	CcSEcCtD
Lomitapide—Nausea—Prednisolone—multiple sclerosis	0.000211	0.000878	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—multiple sclerosis	0.000209	0.000872	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000208	0.000868	CcSEcCtD
Lomitapide—Vomiting—Triamcinolone—multiple sclerosis	0.000207	0.000864	CcSEcCtD
Lomitapide—Vomiting—Methylprednisolone—multiple sclerosis	0.000207	0.000863	CcSEcCtD
Lomitapide—Headache—Triamcinolone—multiple sclerosis	0.000204	0.000852	CcSEcCtD
Lomitapide—Headache—Methylprednisolone—multiple sclerosis	0.000204	0.00085	CcSEcCtD
Lomitapide—Abdominal pain—Prednisone—multiple sclerosis	0.000204	0.000849	CcSEcCtD
Lomitapide—Body temperature increased—Prednisone—multiple sclerosis	0.000204	0.000849	CcSEcCtD
Lomitapide—Diarrhoea—Betamethasone—multiple sclerosis	0.000202	0.000844	CcSEcCtD
Lomitapide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000202	0.000844	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000196	0.000818	CcSEcCtD
Lomitapide—Dizziness—Dexamethasone—multiple sclerosis	0.000196	0.000816	CcSEcCtD
Lomitapide—Dizziness—Betamethasone—multiple sclerosis	0.000196	0.000816	CcSEcCtD
Lomitapide—Nausea—Triamcinolone—multiple sclerosis	0.000194	0.000808	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—multiple sclerosis	0.000193	0.000806	CcSEcCtD
Lomitapide—Nausea—Methylprednisolone—multiple sclerosis	0.000193	0.000806	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000193	0.0118	CbGpPWpGaD
Lomitapide—Somnolence—Methotrexate—multiple sclerosis	0.000191	0.000798	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP27B1—multiple sclerosis	0.00019	0.0117	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP24A1—multiple sclerosis	0.00019	0.0117	CbGpPWpGaD
Lomitapide—Dyspepsia—Methotrexate—multiple sclerosis	0.00019	0.00079	CcSEcCtD
Lomitapide—Vomiting—Dexamethasone—multiple sclerosis	0.000188	0.000784	CcSEcCtD
Lomitapide—Vomiting—Betamethasone—multiple sclerosis	0.000188	0.000784	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—multiple sclerosis	0.000187	0.000781	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000186	0.000775	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000186	0.0114	CbGpPWpGaD
Lomitapide—Fatigue—Methotrexate—multiple sclerosis	0.000186	0.000774	CcSEcCtD
Lomitapide—Headache—Dexamethasone—multiple sclerosis	0.000185	0.000773	CcSEcCtD
Lomitapide—Headache—Betamethasone—multiple sclerosis	0.000185	0.000773	CcSEcCtD
Lomitapide—Asthenia—Prednisone—multiple sclerosis	0.000185	0.000771	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000177	0.00074	CcSEcCtD
Lomitapide—Diarrhoea—Prednisone—multiple sclerosis	0.000176	0.000735	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000176	0.000734	CcSEcCtD
Lomitapide—Nausea—Betamethasone—multiple sclerosis	0.000176	0.000733	CcSEcCtD
Lomitapide—Nausea—Dexamethasone—multiple sclerosis	0.000176	0.000733	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000174	0.0107	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000174	0.0107	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GPC5—multiple sclerosis	0.000174	0.0107	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000172	0.0105	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000172	0.0105	CbGpPWpGaD
Lomitapide—Dizziness—Prednisone—multiple sclerosis	0.00017	0.00071	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—multiple sclerosis	0.00017	0.00071	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—multiple sclerosis	0.00017	0.00071	CcSEcCtD
Lomitapide—Vomiting—Prednisone—multiple sclerosis	0.000164	0.000683	CcSEcCtD
Lomitapide—Headache—Prednisone—multiple sclerosis	0.000161	0.000673	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000157	0.00965	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000157	0.00965	CbGpPWpGaD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000156	0.00959	CbGpPWpGaD
Lomitapide—Asthenia—Methotrexate—multiple sclerosis	0.000155	0.000644	CcSEcCtD
Lomitapide—Nausea—Prednisone—multiple sclerosis	0.000153	0.000638	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—multiple sclerosis	0.000147	0.000614	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000146	0.00894	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—RRM1—multiple sclerosis	0.000144	0.00885	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000143	0.00878	CbGpPWpGaD
Lomitapide—Dizziness—Methotrexate—multiple sclerosis	0.000142	0.000594	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000141	0.00866	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000141	0.00866	CbGpPWpGaD
Lomitapide—Vomiting—Methotrexate—multiple sclerosis	0.000137	0.000571	CcSEcCtD
Lomitapide—Headache—Methotrexate—multiple sclerosis	0.000135	0.000562	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000135	0.00828	CbGpPWpGaD
Lomitapide—Nausea—Methotrexate—multiple sclerosis	0.000128	0.000533	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000122	0.00751	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000112	0.00686	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000106	0.00652	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000103	0.00633	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	9.87e-05	0.00606	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	9.79e-05	0.00601	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.6e-05	0.0059	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—IL6—multiple sclerosis	9.59e-05	0.00589	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40—multiple sclerosis	9.41e-05	0.00578	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	9.28e-05	0.0057	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.97e-05	0.00551	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.76e-05	0.00538	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	8.48e-05	0.0052	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—BCHE—multiple sclerosis	8.28e-05	0.00508	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	8.17e-05	0.00501	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	7.64e-05	0.00469	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.49e-05	0.0046	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.49e-05	0.0046	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.39e-05	0.00454	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.39e-05	0.00454	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD86—multiple sclerosis	7.36e-05	0.00452	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL10—multiple sclerosis	7.21e-05	0.00443	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	7.21e-05	0.00443	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.02e-05	0.00431	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.86e-05	0.00421	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.47e-05	0.00397	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	6.43e-05	0.00395	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	6.36e-05	0.0039	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.81e-05	0.00357	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.37e-05	0.00329	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—APOE—multiple sclerosis	4.98e-05	0.00306	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.78e-05	0.00293	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.65e-05	0.00285	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.32e-05	0.00265	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—POMC—multiple sclerosis	4.28e-05	0.00263	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.24e-05	0.0026	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.92e-05	0.0024	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—multiple sclerosis	3.9e-05	0.00239	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.78e-05	0.00232	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.77e-05	0.00231	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.73e-05	0.00229	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.62e-05	0.00222	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.19e-05	0.00196	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.17e-05	0.00195	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SRM—multiple sclerosis	2.95e-05	0.00181	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.94e-05	0.00181	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.86e-05	0.00176	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.75e-05	0.00169	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.53e-05	0.00155	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.00117	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SRM—multiple sclerosis	1.82e-05	0.00112	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.69e-05	0.00103	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RRM1—multiple sclerosis	1.58e-05	0.000968	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.45e-05	0.000893	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.45e-05	0.000891	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.42e-05	0.000874	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.36e-05	0.000832	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.28e-05	0.000787	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.28e-05	0.000787	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.17e-05	0.00072	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.71e-06	0.000596	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.11e-06	0.000559	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BCHE—multiple sclerosis	9.06e-06	0.000556	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.58e-06	0.000342	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APOE—multiple sclerosis	5.45e-06	0.000334	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—POMC—multiple sclerosis	4.68e-06	0.000287	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—multiple sclerosis	4.27e-06	0.000262	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APOE—multiple sclerosis	3.36e-06	0.000206	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—POMC—multiple sclerosis	2.88e-06	0.000177	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—multiple sclerosis	2.63e-06	0.000161	CbGpPWpGaD
